142 related articles for article (PubMed ID: 34998604)
1. Analysis of immune response induction mechanisms implicating the dose-sparing effect of transcutaneous immunization using a self-dissolving microneedle patch.
Ito S; Hirobe S; Yamashita R; Sugiyama A; Takeuchi H; Eguchi R; Yoshida J; Oyamada T; Tachibana M; Okada N
Vaccine; 2022 Feb; 40(6):862-872. PubMed ID: 34998604
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of immune induction by transcutaneous vaccination using dissolving microneedle patches in mice.
Hirobe S; Susai R; Takeuchi H; Eguchi R; Ito S; Quan YS; Kamiyama F; Okada N
Int J Pharm; 2021 May; 601():120563. PubMed ID: 33811967
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Activity of CpG-Oligonucleotide Administered Transcutaneously in Combination with Vaccination Using a Self-Dissolving Microneedle Patch in Mice.
Hirobe S; Kawakita T; Yamasaki T; Ito S; Tachibana M; Okada N
Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960226
[TBL] [Abstract][Full Text] [Related]
4. Characteristic of K3 (CpG-ODN) as a Transcutaneous Vaccine Formulation Adjuvant.
Ito S; Hirobe S; Kawakita T; Saito M; Quan YS; Kamiyama F; Ishii KJ; Nagao M; Fujisawa T; Tachibana M; Okada N
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32183437
[TBL] [Abstract][Full Text] [Related]
5. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.
Matsuo K; Yokota Y; Zhai Y; Quan YS; Kamiyama F; Mukai Y; Okada N; Nakagawa S
J Control Release; 2012 Jul; 161(1):10-7. PubMed ID: 22306332
[TBL] [Abstract][Full Text] [Related]
6. Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection.
Lopez PA; Denny M; Hartmann AK; Alflen A; Probst HC; von Stebut E; Tenzer S; Schild H; Stassen M; Langguth P; Radsak MP
J Dermatol Sci; 2017 Sep; 87(3):252-259. PubMed ID: 28655469
[TBL] [Abstract][Full Text] [Related]
7. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
8. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.
Matsuo K; Okamoto H; Kawai Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
J Neuroimmunol; 2014 Jan; 266(1-2):1-11. PubMed ID: 24315156
[TBL] [Abstract][Full Text] [Related]
9. Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device.
Hirobe S; Azukizawa H; Matsuo K; Zhai Y; Quan YS; Kamiyama F; Suzuki H; Katayama I; Okada N; Nakagawa S
Pharm Res; 2013 Oct; 30(10):2664-74. PubMed ID: 23775442
[TBL] [Abstract][Full Text] [Related]
10. Current Progress in Particle-Based Systems for Transdermal Vaccine Delivery.
Pielenhofer J; Sohl J; Windbergs M; Langguth P; Radsak MP
Front Immunol; 2020; 11():266. PubMed ID: 32174915
[TBL] [Abstract][Full Text] [Related]
11. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch.
Hirobe S; Azukizawa H; Hanafusa T; Matsuo K; Quan YS; Kamiyama F; Katayama I; Okada N; Nakagawa S
Biomaterials; 2015 Jul; 57():50-8. PubMed ID: 25913250
[TBL] [Abstract][Full Text] [Related]
12. Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza.
Matsuo K; Hirobe S; Yokota Y; Ayabe Y; Seto M; Quan YS; Kamiyama F; Tougan T; Horii T; Mukai Y; Okada N; Nakagawa S
J Control Release; 2012 Jun; 160(3):495-501. PubMed ID: 22516091
[TBL] [Abstract][Full Text] [Related]
13. Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria.
Hirobe S; Matsuo K; Quan YS; Kamiyama F; Morito H; Asada H; Takaya Y; Mukai Y; Okada N; Nakagawa S
Vaccine; 2012 Feb; 30(10):1847-54. PubMed ID: 22230592
[TBL] [Abstract][Full Text] [Related]
14. Induction of anti-chlamydial mucosal immunity by transcutaneous immunization is enhanced by topical application of GM-CSF.
Hickey DK; Bao S; Ikeda LT; Carey AJ; Beagley KW
Curr Mol Med; 2005 Sep; 5(6):599-605. PubMed ID: 16178770
[TBL] [Abstract][Full Text] [Related]
15. Transdermal influenza immunization with vaccine-coated microneedle arrays.
Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Sullivan SP; Compans RW; Prausnitz MR; Skountzou I
PLoS One; 2009; 4(3):e4773. PubMed ID: 19274084
[TBL] [Abstract][Full Text] [Related]
16. Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination.
Naito S; Ito Y; Kiyohara T; Kataoka M; Ochiai M; Takada K
Vaccine; 2012 Feb; 30(6):1191-7. PubMed ID: 22172508
[TBL] [Abstract][Full Text] [Related]
17. Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation.
Scheiblhofer S; Strobl A; Hoepflinger V; Thalhamer T; Steiner M; Thalhamer J; Weiss R
Vaccine; 2017 Mar; 35(14):1802-1809. PubMed ID: 28117172
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous immunization in auricle skin induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
Nagano H; Jimura T; Nagano M; Makise T; Miyashita K; Kurono Y
Auris Nasus Larynx; 2017 Aug; 44(4):411-416. PubMed ID: 27637556
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticulate mediated transcutaneous immunization: Myth or reality.
Kaurav M; Minz S; Sahu K; Kumar M; Madan J; Pandey RS
Nanomedicine; 2016 May; 12(4):1063-1081. PubMed ID: 26767517
[TBL] [Abstract][Full Text] [Related]
20. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.
Matsuo K; Hirobe S; Okada N; Nakagawa S
Vaccine; 2013 May; 31(19):2403-15. PubMed ID: 23523401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]